Neovascular age-related macular degeneration complicated by large submacular hemorrhage managed with faricimab monotherapy. [PDF]
Lim J, Cho H, Ramkumar H, Adrean SD.
europepmc +1 more source
Choroidal changes after antiVEGF in neovascular age-related macular degeneration with type 1 and 3 macular neovascularization. [PDF]
Bartol-Puyal FA +6 more
europepmc +1 more source
Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism. [PDF]
Veernala I +5 more
europepmc +1 more source
Multimodal artificial intelligence in retinal vascular and neovascular macular diseases: a systematic review of diagnostic and prognostic applications. [PDF]
Khathami AA +14 more
europepmc +1 more source
Management of submacular hemorrhage secondary to age-related macular degeneration with vitrectomy and subretinal tissue plasminogen activator injection: Outcomes and prognostic factors. [PDF]
Li MM, Zhang H, Cen ZM, Su DW.
europepmc +1 more source
Real-World Clinical Usage and Safety Profile of Intravitreal Pegcetacoplan in Age-Related Macular Degeneration-Associated Geographic Atrophy. [PDF]
Abbas A, Singaravelu J, Fein JG.
europepmc +1 more source
One year outcomes of intravitreal faricimab for treatment Naïve neovascular AMD and associations with baseline aqueous humor cytokines. [PDF]
Inoda S +10 more
europepmc +1 more source
Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. [PDF]
Tamai R +4 more
europepmc +1 more source
Navigating the Decision to Discontinue Intravitreal Injection Therapy in End-Stage Neovascular Age-Related Macular Degeneration. [PDF]
Bennie J, Ramsey DJ.
europepmc +1 more source
Biomarker-Specific Test-Retest Repeatabilities of Microperimetry in Neovascular Age-Related Macular Degeneration. [PDF]
Hinterhuber L +9 more
europepmc +1 more source

